Cargando…
Novel animal model of combined generalized and focal epilepsy
Thioredoxin, encoded by Txn1, is a critical antioxidant that protects against oxidative damage by regulating the dithiol/disulfide balance of interacting proteins. We recently discovered the Adem rat, an epileptic rat harboring the Txn1‐F54L mutation, characterized by wild running and vacuolar degen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544055/ https://www.ncbi.nlm.nih.gov/pubmed/35532890 http://dx.doi.org/10.1111/epi.17295 |
_version_ | 1784804514809774080 |
---|---|
author | Ohmori, Iori Ouchida, Mamoru Shinohara, Masakazu Kobayashi, Kiyoka Ishida, Saeko Mashimo, Tomoji |
author_facet | Ohmori, Iori Ouchida, Mamoru Shinohara, Masakazu Kobayashi, Kiyoka Ishida, Saeko Mashimo, Tomoji |
author_sort | Ohmori, Iori |
collection | PubMed |
description | Thioredoxin, encoded by Txn1, is a critical antioxidant that protects against oxidative damage by regulating the dithiol/disulfide balance of interacting proteins. We recently discovered the Adem rat, an epileptic rat harboring the Txn1‐F54L mutation, characterized by wild running and vacuolar degeneration in the midbrain. This study aimed to characterize the classification of epilepsy in Adem rats. We performed simultaneous video‐electroencephalographic recordings, magnetic resonance imaging, neurotransmitter measurements using gas chromatography–mass spectrometry (GC‐MS), and immunohistochemistry. Adem rats exhibited absence, tonic, and focal seizures. The type of epilepsy was classified as combined generalized and focal epilepsy. Neurotransmitters in the midbrain and cortex were measured at 3 weeks of age, when neuronal cell death occurs in the midbrain. The results of GC‐MS ruled out the dominance of the excitatory system in the midbrain and cortex of Adem rats. Activation of astrocytes and microglia was more pronounced at 5 weeks of age, at which time epileptic seizures occurred frequently. The underlying pathology in Adem rats remains unknown. However, glial cell activation and inflammation may play a significant role in the occurrence of epilepsy. |
format | Online Article Text |
id | pubmed-9544055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95440552022-10-14 Novel animal model of combined generalized and focal epilepsy Ohmori, Iori Ouchida, Mamoru Shinohara, Masakazu Kobayashi, Kiyoka Ishida, Saeko Mashimo, Tomoji Epilepsia Brief Communication Thioredoxin, encoded by Txn1, is a critical antioxidant that protects against oxidative damage by regulating the dithiol/disulfide balance of interacting proteins. We recently discovered the Adem rat, an epileptic rat harboring the Txn1‐F54L mutation, characterized by wild running and vacuolar degeneration in the midbrain. This study aimed to characterize the classification of epilepsy in Adem rats. We performed simultaneous video‐electroencephalographic recordings, magnetic resonance imaging, neurotransmitter measurements using gas chromatography–mass spectrometry (GC‐MS), and immunohistochemistry. Adem rats exhibited absence, tonic, and focal seizures. The type of epilepsy was classified as combined generalized and focal epilepsy. Neurotransmitters in the midbrain and cortex were measured at 3 weeks of age, when neuronal cell death occurs in the midbrain. The results of GC‐MS ruled out the dominance of the excitatory system in the midbrain and cortex of Adem rats. Activation of astrocytes and microglia was more pronounced at 5 weeks of age, at which time epileptic seizures occurred frequently. The underlying pathology in Adem rats remains unknown. However, glial cell activation and inflammation may play a significant role in the occurrence of epilepsy. John Wiley and Sons Inc. 2022-05-28 2022-07 /pmc/articles/PMC9544055/ /pubmed/35532890 http://dx.doi.org/10.1111/epi.17295 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Communication Ohmori, Iori Ouchida, Mamoru Shinohara, Masakazu Kobayashi, Kiyoka Ishida, Saeko Mashimo, Tomoji Novel animal model of combined generalized and focal epilepsy |
title | Novel animal model of combined generalized and focal epilepsy |
title_full | Novel animal model of combined generalized and focal epilepsy |
title_fullStr | Novel animal model of combined generalized and focal epilepsy |
title_full_unstemmed | Novel animal model of combined generalized and focal epilepsy |
title_short | Novel animal model of combined generalized and focal epilepsy |
title_sort | novel animal model of combined generalized and focal epilepsy |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544055/ https://www.ncbi.nlm.nih.gov/pubmed/35532890 http://dx.doi.org/10.1111/epi.17295 |
work_keys_str_mv | AT ohmoriiori novelanimalmodelofcombinedgeneralizedandfocalepilepsy AT ouchidamamoru novelanimalmodelofcombinedgeneralizedandfocalepilepsy AT shinoharamasakazu novelanimalmodelofcombinedgeneralizedandfocalepilepsy AT kobayashikiyoka novelanimalmodelofcombinedgeneralizedandfocalepilepsy AT ishidasaeko novelanimalmodelofcombinedgeneralizedandfocalepilepsy AT mashimotomoji novelanimalmodelofcombinedgeneralizedandfocalepilepsy |